$24.29
0.893.8%
Last update: Nov 9, 6:08 PM
Legend Biotech Corp
LEGNNASDAQ
Legend Biotech fell 23.1% from $31.59 to $24.29, behind the S&P 500's +10.5%. Its worst day was Jun 18 (−16.7%), and its low came Feb 4 at $16.65.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.05 beat the $-0.12 estimate on $272.3M revenue (est. $276.0M).
−2.7% · S&P 500 +0.1%
Legend Biotech closed at its lowest level of the year, 47.3% below where the year started.
Story events cover the past 12 months · Times ET
−0.1% · S&P 500 −0.5%
EPS of $0.01 beat the $-0.18 estimate on $306.3M revenue (est. $306.0M).
+2.2% · S&P 500 −0.2%
Legend Biotech shares rose 18.4%, while the S&P 500 fell 0.2%.
+18.4% · S&P 500 −0.2%
Legend Biotech shares rose 12.3%, while the S&P 500 fell 0.4%.
+12.3% · S&P 500 −0.4%
EPS of $-0.03 beat the $-0.14 estimate on $305.1M revenue (est. $306.9M).
+10.5% · S&P 500 −0.2%
Legend Biotech closed at its highest level of the year, 14.8% above where the year started.
+42.2%, the year's best day, on 15M shares, the year's heaviest volume · S&P 500 +0.1%
Legend Biotech Corporation (NASDAQ:LEGN) ("Legend Biotech" or the "Company"), a global leader in cell therapy, today announced that it has commenced an underwritten public offering of $225 million of Ame…
−16.7%, the year's worst day · S&P 500 +1.0%
Legend Biotech Corporation (NASDAQ:LEGN) ("Legend Biotech" or the "Company"), a global leader in cell therapy, today announced that Ying Huang, Ph.D., has stepped down as Chief Executive Officer and as a
−13.3% · S&P 500 0.0%
EPS of $0.16 missed the $0.25 estimate on $387.5M revenue (est. $353.3M).
+5.7% · S&P 500 −0.3%
Where it ended: a close of $24.29 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 10, 2026 (EPS est. $0.01, revenue est. $359.9M).
Nothing in the past 12 months.
All LEGN dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LEGN and SPY from Benzinga historical bars. Not investment advice.
